Effect of opportunistic salpingectomy on ovarian reserve in patients undergoing hysterectomy for benign indications
暂无分享,去创建一个
Ahmet | D. Şimşek | A. Akdemir | D. Taşkıran | S. Özşener | A. Ergenoğlu | Çağrı Güven | Özgür Yeniel
[1] S. Scheib. A Laparoendoscopic Single-site Surgical Approach to Laparoscopic Salpingectomy. , 2017, Journal of minimally invasive gynecology.
[2] A. Strandell,et al. Efficacy of salpingectomy at hysterectomy to reduce the risk of epithelial ovarian cancer: a systematic review , 2017, BJOG : an international journal of obstetrics and gynaecology.
[3] D. Antosh,et al. Prophylactic salpingectomy during vaginal hysterectomy: A feasibility study: 12 , 2017 .
[4] R. Kho,et al. Operative Outcomes of Opportunistic Bilateral Salpingectomy at the Time of Benign Hysterectomy in Low-Risk Premenopausal Women: A Systematic Review. , 2017, Journal of minimally invasive gynecology.
[5] Yifeng Wang,et al. Comparing the effect of laparoscopic supracervical and total hysterectomy for uterine fibroids on ovarian reserve by assessing serum anti-mullerian hormone levels: a prospective cohort study. , 2015, Journal of minimally invasive gynecology.
[6] C. Mathers,et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.
[7] H. Grönberg,et al. Ovarian cancer risk after salpingectomy: a nationwide population-based study. , 2015, Journal of the National Cancer Institute.
[8] D. Huntsman,et al. Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention. , 2014, American journal of obstetrics and gynecology.
[9] W. Parker. Ovarian conservation versus bilateral oophorectomy at the time of hysterectomy for benign disease. , 2014, Menopause.
[10] E. Carey,et al. Short-term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: a pilot randomized controlled trial. , 2013, Fertility and sterility.
[11] E. Ng,et al. Comparison of serum anti-Mullerian hormone levels following hysterectomy and myomectomy for benign gynaecological conditions. , 2013, European journal of obstetrics, gynecology, and reproductive biology.
[12] F. Kung,et al. Ovarian response to gonadotropins in patients with tubal factor infertility: salpingectomy versus nonsalpingectomy. , 2013, Journal of minimally invasive gynecology.
[13] C. Lewis,et al. Antral follicle count predicts natural menopause in a population-based sample: the Coronary Artery Risk Development in Young Adults Women’s Study , 2013, Menopause.
[14] F. Zullo,et al. Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere. , 2013, Gynecologic oncology.
[15] C. Atabekoğlu,et al. The effect of total abdominal hysterectomy on serum anti-Müllerian hormone levels: a pilot study , 2012, Climacteric : the journal of the International Menopause Society.
[16] J. Wischhusen,et al. The post-reproductive Fallopian tube: better removed? , 2011, Human reproduction.
[17] J. Manson,et al. Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women's Health Initiative Observational Study. , 2011, Archives of internal medicine.
[18] G. Morgante,et al. Does salpingectomy affect the ipsilateral ovarian response to gonadotropin during in vitro fertilization-embryo transfer cycles? , 2011, Fertility and sterility.
[19] S. Cox,et al. Elective Oophorectomy in the United States: Trends and In-Hospital Complications, 1998–2006 , 2010, Obstetrics and gynecology.
[20] W. Parker. Bilateral oophorectomy versus ovarian conservation: effects on long-term women's health. , 2010, Journal of minimally invasive gynecology.
[21] M. Koppán,et al. Effect of the removal of the Fallopian tube during hysterectomy on ovarian survival: the orphan ovary syndrome. , 2009, European journal of obstetrics, gynecology, and reproductive biology.
[22] J. Manson,et al. Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses’ Health Study , 2009, Obstetrics and gynecology.
[23] Jiaquan Xu,et al. Deaths: final data for 2005. , 2008, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[24] Brian Morrow,et al. Inpatient hysterectomy surveillance in the United States, 2000-2004. , 2008, American journal of obstetrics and gynecology.
[25] M. Sezik,et al. Total salpingectomy during abdominal hysterectomy: Effects on ovarian reserve and ovarian stromal blood flow , 2007, The journal of obstetrics and gynaecology research.
[26] M. Broder,et al. Ovarian Conservation at the Time of Hysterectomy for Benign Disease , 2005, Obstetrics and gynecology.
[27] Mariza de Andrade,et al. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. , 2006, The Lancet. Oncology.
[28] L. Nardo,et al. Ovarian response to gonadotropins after laparoscopic salpingectomy or the division of fallopian tubes for hydrosalpinges. , 2006, Fertility and sterility.
[29] E. Nahas,et al. Effect of Total Abdominal Hysterectomy on Ovarian Blood Supply in Women of Reproductive Age , 2005, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[30] P. V. van Diest,et al. DYSPLASTIC CHANGES IN PROPHYLACTICALLY REMOVED FALLOPIAN TUBES OF WOMEN PREDISPOSED TO DEVELOP OVARIAN/FALLOPIAN TUBE CANCER , 2003, International Journal of Gynecologic Cancer.
[31] Eun-Hee Ahn,et al. Effect of hysterectomy on conserved ovarian function. , 2001, Yonsei medical journal.
[32] P. V. van Diest,et al. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer , 2001, The Journal of pathology.
[33] Alan D. Lopez,et al. Healthy life expectancy in 191 countries, 1999 , 2001, The Lancet.
[34] W. Schoolcraft,et al. Laparoscopic management of hydrosalpinges before in vitro fertilization-embryo transfer: salpingectomy versus proximal tubal occlusion. , 2001, Fertility and sterility.
[35] J. Bidart,et al. Detection of minimal levels of serum anti-Müllerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay. , 2000, The Journal of clinical endocrinology and metabolism.
[36] P. Donahoe,et al. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[37] A. Heintz,et al. The effect of hysterectomy and endometrial ablation on follicle stimulating hormone (FSH) levels up to 1 year after surgery. , 1998, Maturitas.
[38] P. Sarrel,et al. The effect of hysterectomy on the age at ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature review. , 1987, Fertility and sterility.